The EU votes to ease restrictions on CRISPR gene-edited crops: climate-smart farming breakthrough, or corporate GMO takeover?
The European Parliament voted on 17 June on new rules to allow crops developed with CRISPR and other new genomic techniques (NGTs) — the EU's biggest GMO policy shift since the 1990s. Under the proposal, 'NGT-1' crops (targeted changes that could arise through natural mutation) would be treated like conventional crops; heavier modifications stay regulated. Scientists backing the reform argue NGT-1 plants carry no foreign DNA and can help farmers adapt to climate change while cutting pesticide use. But Friends of the Earth Europe and environmental groups warn that the real beneficiaries are Bayer, Corteva and Chem China/Syngenta — who will extend patent monopolies over seeds — while farmers face contamination costs and consumers lose labelling rights that majorities have supported for decades.
The summary above is a neutral framing. Below, each side reports the same story in its own words — judge for yourself.
The European Parliament voted on new rules treating 'NGT-1' CRISPR-edited crops — those with only limited, targeted changes that could also arise through natural mutation — like conventional crops. Unlike classic GMOs, which insert foreign DNA from another species, NGT-1 plants alter only existing genes, making them scientifically distinct, proponents say. Detlef Weigel, director of the molecular biology department at Germany's Max Planck Institute for Biology, told DW: 'If a CRISPR-edited plant contains no foreign DNA and carries only changes that could also arise through natural mutation processes, then from a scientific point of view, there is no convincing reason to treat it like a classical transgenic plant.' Supporters say NGT-1 crops could help farmers adapt to climate change with drought- and pest-resistant varieties, and reduce reliance on fertilizers and pesticides.
Friends of the Earth Europe says the reform reveals a 'stark divide': a handful of biotech and pesticide giants — Bayer, Corteva and Chem China/Syngenta — reap the profits while farmers, consumers and nature bear the risks and losses. Because the draft law excludes most new GMOs from existing labelling requirements, European consumers — who have consistently rejected GMOs for over two decades — are denied transparency and choice. The patent system, FoE warns, lets corporations claim ownership over natural seeds and conventionally bred products, blocking small farmers and breeders from accessing key genetic resources. And without liability clauses, corporations can market new GMOs with no accountability for potential harm. Organic and conventional (non-GMO) farmers face the added burden and cost of preventing contamination from unlabelled gene-edited crops spreading into their fields.
